See more : Ease2pay N.V. (EAS2P.AS) Income Statement Analysis – Financial Results
Complete financial analysis of Formosa Laboratories, Inc. (4746.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Formosa Laboratories, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Selic Corp Public Company Limited (SELIC.BK) Income Statement Analysis – Financial Results
- PT Pembangunan Graha Lestari Indah Tbk (PGLI.JK) Income Statement Analysis – Financial Results
- CannLabs, Inc. (CANL) Income Statement Analysis – Financial Results
- Exxon Mobil Corporation (XOM.SW) Income Statement Analysis – Financial Results
- Madison Square Garden Sports Corp. (MSGS) Income Statement Analysis – Financial Results
Formosa Laboratories, Inc. (4746.TW)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.formosalab.com
About Formosa Laboratories, Inc.
Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.36B | 3.77B | 3.14B | 3.08B | 2.76B | 2.69B | 2.54B | 3.19B | 2.60B | 2.50B | 2.47B | 2.52B | 2.63B | 2.51B | 0.00 |
| Cost of Revenue | 2.44B | 2.38B | 2.17B | 2.13B | 1.93B | 1.77B | 1.53B | 1.93B | 1.79B | 1.81B | 2.13B | 2.13B | 2.04B | 1.91B | 0.00 |
| Gross Profit | 1.92B | 1.39B | 971.44M | 945.17M | 825.26M | 914.12M | 1.01B | 1.26B | 805.99M | 686.69M | 339.32M | 391.21M | 585.23M | 597.95M | 0.00 |
| Gross Profit Ratio | 44.11% | 36.92% | 30.91% | 30.73% | 29.91% | 34.01% | 39.61% | 39.43% | 31.04% | 27.51% | 13.72% | 15.50% | 22.29% | 23.86% | 0.00% |
| Research & Development | 841.87M | 777.02M | 700.20M | 548.18M | 446.38M | 458.98M | 294.55M | 271.82M | 208.98M | 179.56M | 194.28M | 172.30M | 141.56M | 101.69M | 0.00 |
| General & Administrative | 245.17M | 234.22M | 282.21M | 203.04M | 197.74M | 182.29M | 163.19M | 152.25M | 131.70M | 115.18M | 110.03M | 104.97M | 111.00M | 91.02M | 0.00 |
| Selling & Marketing | 187.77M | 187.12M | 170.92M | 135.20M | 147.42M | 215.63M | 169.89M | 169.94M | 139.75M | 118.01M | 110.05M | 76.97M | 88.75M | 83.95M | 0.00 |
| SG&A | 432.95M | 421.34M | 453.14M | 338.25M | 345.16M | 397.91M | 333.08M | 322.20M | 271.44M | 233.18M | 220.08M | 181.94M | 199.75M | 174.97M | 0.00 |
| Other Expenses | 0.00 | 179.28M | 1.27B | 360.33M | -33.34M | 103.47M | -45.09M | -18.94M | 51.62M | 60.12M | 43.56M | 9.85M | 5.28M | 7.33M | 0.00 |
| Operating Expenses | 1.25B | 1.20B | 1.15B | 886.43M | 791.54M | 856.89M | 627.63M | 594.02M | 480.42M | 412.74M | 414.36M | 354.23M | 341.31M | 276.66M | 0.00 |
| Cost & Expenses | 3.69B | 3.57B | 3.32B | 3.02B | 2.73B | 2.63B | 2.16B | 2.53B | 2.27B | 2.22B | 2.55B | 2.49B | 2.38B | 2.18B | 0.00 |
| Interest Income | 23.71M | 2.14M | 357.00K | 1.07M | 2.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.00K | 144.00K | 48.00K | 0.00 |
| Interest Expense | 34.74M | 19.32M | 28.05M | 28.52M | 28.71M | 17.59M | 21.89M | 32.11M | 33.02M | 24.06M | 26.52M | 10.02M | 3.22M | 3.77M | 0.00 |
| Depreciation & Amortization | 488.33M | 470.92M | 472.52M | 448.26M | 383.38M | 317.69M | 283.11M | 265.10M | 231.12M | 193.50M | 150.60M | 133.58M | 119.70M | 106.03M | 0.00 |
| EBITDA | 1.16B | 851.76M | 1.58B | 870.23M | 372.91M | 481.65M | 616.22M | 928.52M | 556.70M | 467.45M | 119.11M | 165.69M | 378.49M | 395.32M | 0.00 |
| EBITDA Ratio | 26.68% | 22.62% | 50.18% | 28.30% | 13.85% | 17.85% | 24.27% | 28.52% | 23.41% | 21.13% | 4.80% | 6.51% | 14.59% | 15.73% | 0.00% |
| Operating Income | 674.98M | 380.85M | 1.10B | 420.42M | -2.21M | 57.23M | 378.20M | 663.42M | 325.57M | 273.95M | -75.05M | 36.98M | 243.92M | 321.29M | 0.00 |
| Operating Income Ratio | 15.48% | 10.11% | 35.06% | 13.67% | -0.08% | 2.13% | 14.89% | 20.80% | 12.54% | 10.97% | -3.03% | 1.46% | 9.29% | 12.82% | 0.00% |
| Total Other Income/Expenses | -532.58M | -47.67M | 1.26B | 333.16M | -64.64M | 89.74M | -66.89M | -51.11M | 18.26M | 35.90M | 16.66M | -15.61M | 11.65M | -36.14M | 0.00 |
| Income Before Tax | 142.39M | 333.18M | 1.09B | 361.17M | -40.21M | 146.97M | 311.31M | 612.32M | 343.83M | 309.84M | -58.39M | 21.37M | 254.89M | 285.15M | 0.00 |
| Income Before Tax Ratio | 3.27% | 8.85% | 34.61% | 11.74% | -1.46% | 5.47% | 12.26% | 19.20% | 13.24% | 12.41% | -2.36% | 0.85% | 9.71% | 11.38% | 0.00% |
| Income Tax Expense | 194.65M | 116.37M | 44.01M | 31.99M | 856.00K | 22.32M | 76.10M | 128.88M | 61.44M | 47.35M | 11.01M | 16.37M | 23.83M | 38.53M | 0.00 |
| Net Income | 126.24M | 216.81M | 1.25B | 400.03M | -41.06M | 176.82M | 238.65M | 483.44M | 282.39M | 262.50M | -69.40M | 5.00M | 231.07M | 246.62M | 0.00 |
| Net Income Ratio | 2.90% | 5.76% | 39.75% | 13.01% | -1.49% | 6.58% | 9.40% | 15.16% | 10.87% | 10.52% | -2.81% | 0.20% | 8.80% | 9.84% | 0.00% |
| EPS | 1.05 | 1.80 | 10.92 | 3.78 | -0.41 | 1.78 | 2.62 | 5.48 | 3.31 | 3.10 | -0.97 | 0.08 | 3.44 | 3.99 | 0.00 |
| EPS Diluted | 1.05 | 1.79 | 10.32 | 3.46 | -0.41 | 1.73 | 2.55 | 5.21 | 3.09 | 2.97 | -0.97 | 0.08 | 3.43 | 3.95 | 0.00 |
| Weighted Avg Shares Out | 120.26M | 120.26M | 114.36M | 105.70M | 99.78M | 99.28M | 90.93M | 88.22M | 85.35M | 84.56M | 71.37M | 67.06M | 67.17M | 61.90M | 36.06M |
| Weighted Avg Shares Out (Dil) | 120.49M | 120.88M | 121.50M | 118.20M | 100.10M | 102.20M | 95.09M | 94.16M | 94.59M | 90.36M | 71.58M | 67.25M | 67.34M | 62.40M | 36.06M |
Source: https://incomestatements.info
Category: Stock Reports